Drug intelligence / Profile preview

Ziyinliangxue

Development stage
Unknown
Lead developer
Shanghai Municipal Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Ziyinliangxue is a Traditional Chinese Medicine (TCM) formula developed by the Shanghai Traditional Chinese Medicine Hospital, specifically indicated for the treatment of chronic glomerulonephritis (CGN). The formula is designed based on the TCM principle of nourishing Yin and cooling the blood (Ziyin Liangxue) to address the syndrome of Yin deficiency and internal heat often observed in renal patients. It typically consists of a combination of herbal ingredients such as Rehmannia glutinosa and Scrophularia ningpoensis. Clinically, it is used to reduce proteinuria and hematuria, modulate the immune response, and slow the progression of renal fibrosis. Research into its mechanism suggests it acts by inhibiting inflammatory pathways, regulating the Th17/Treg cell balance, and downregulating pro-fibrotic factors like TGF-beta1.

Other names
Ziyin Liangxue decoctionZiyin Liangxue formulaZiyin Liangxue granules滋阴凉血方
02

Targets

IL-6 (Interleukin 6)TGFB1 (Transforming growth factor Beta-1 proprotein)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Ziyinliangxue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ziyinliangxue.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call